DK313388A - 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-oe1aabenzothienooe3,2-eaa-1,2-thiazin-4-carboxamid-1,1-dioxid-forbindelser, farmaceutiske praeparater indeholdende disse og forbindelser til anvendelse som udgangsmateriale ved deres fremstilling - Google Patents

3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-oe1aabenzothienooe3,2-eaa-1,2-thiazin-4-carboxamid-1,1-dioxid-forbindelser, farmaceutiske praeparater indeholdende disse og forbindelser til anvendelse som udgangsmateriale ved deres fremstilling

Info

Publication number
DK313388A
DK313388A DK313388A DK313388A DK313388A DK 313388 A DK313388 A DK 313388A DK 313388 A DK313388 A DK 313388A DK 313388 A DK313388 A DK 313388A DK 313388 A DK313388 A DK 313388A
Authority
DK
Denmark
Prior art keywords
alkyl
carboxamide
dihydro
oxo
thiazin
Prior art date
Application number
DK313388A
Other languages
Danish (da)
English (en)
Other versions
DK313388D0 (da
Inventor
Anthony Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK313388D0 publication Critical patent/DK313388D0/da
Publication of DK313388A publication Critical patent/DK313388A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK313388A 1987-06-10 1988-06-09 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-oe1aabenzothienooe3,2-eaa-1,2-thiazin-4-carboxamid-1,1-dioxid-forbindelser, farmaceutiske praeparater indeholdende disse og forbindelser til anvendelse som udgangsmateriale ved deres fremstilling DK313388A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1987/001357 WO1988009793A1 (en) 1987-06-10 1987-06-10 3,4-DIHYDRO-2-ALKYL-3-OXO-N-ARYL-2H-[1]BENZOTHIENO[3,2-e]-1,2-THIAZINE-4-CARBOXAMIDE-1,1-DIOXIDES
EP88304975A EP0294994B1 (en) 1987-06-10 1988-06-01 3-4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-el]-1,2-thiazine-4-carboxamide-1,1-dioxides

Publications (2)

Publication Number Publication Date
DK313388D0 DK313388D0 (da) 1988-06-09
DK313388A true DK313388A (da) 1988-12-11

Family

ID=55448100

Family Applications (1)

Application Number Title Priority Date Filing Date
DK313388A DK313388A (da) 1987-06-10 1988-06-09 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-oe1aabenzothienooe3,2-eaa-1,2-thiazin-4-carboxamid-1,1-dioxid-forbindelser, farmaceutiske praeparater indeholdende disse og forbindelser til anvendelse som udgangsmateriale ved deres fremstilling

Country Status (28)

Country Link
US (1) US4914101A (cs)
EP (1) EP0294994B1 (cs)
JP (1) JPH078874B2 (cs)
KR (1) KR900006758B1 (cs)
CN (1) CN1019576B (cs)
AT (1) ATE105561T1 (cs)
AU (1) AU593743B2 (cs)
CA (1) CA1300625C (cs)
CZ (1) CZ281857B6 (cs)
DD (1) DD281602A5 (cs)
DE (1) DE3889497T2 (cs)
DK (1) DK313388A (cs)
EG (1) EG18525A (cs)
ES (1) ES2051846T3 (cs)
FI (1) FI89802C (cs)
HU (1) HU203762B (cs)
IE (1) IE63214B1 (cs)
IL (1) IL86602A (cs)
MX (1) MX174093B (cs)
MY (1) MY103572A (cs)
NO (2) NO176277C (cs)
NZ (1) NZ224956A (cs)
PH (1) PH25187A (cs)
PL (1) PL158994B1 (cs)
PT (1) PT87678B (cs)
WO (1) WO1988009793A1 (cs)
YU (1) YU46767B (cs)
ZA (1) ZA884115B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007970A1 (en) * 1989-11-30 1991-06-13 Nippon Hypox Laboratories Incorporated Medicine containing thiazine dioxide derivative
US6340659B1 (en) 1995-12-13 2002-01-22 The Lubrizol Corporation Metal salts of lactones as lubricant additives
JP4250344B2 (ja) 2001-01-29 2009-04-08 インターナショナル・ビジネス・マシーンズ・コーポレーション ワークフローシステム、ワークフローサーバ、および記憶媒体
US8741299B2 (en) 2011-06-20 2014-06-03 The Feinstein Institute For Medical Research Method for treating pathologies associated with hypoxia using MIF inhibitors
US9666805B2 (en) * 2014-11-25 2017-05-30 Northwestern University Bithiophene sulfonamide-based molecular and polymeric semiconductors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
CA1066711A (en) * 1974-08-26 1979-11-20 Hoffmann-La Roche Limited Thiophene derivatives
LU78009A1 (de) * 1977-08-22 1979-05-23 Hoffmann La Roche Verfahren zur herstellung von thiazinderivaten
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
DE2838377A1 (de) * 1978-09-02 1980-03-20 Thomae Gmbh Dr K Neue 4-hydroxy-2h eckige klammer auf 1 eckige klammer zu benzothieno eckige klammer auf 2,3-e eckige klammer zu -1,2- thiazin-3-carboxamid-1,1-dioxide sowie deren salze, deren verwendung und verfahren zu ihrer herstellung
ZA803401B (en) * 1979-06-13 1981-05-27 Hoffmann La Roche Thiazine derivatives
AU5811280A (en) * 1979-06-13 1980-12-18 F. Hoffmann-La Roche Ag Thiazine derivatives

Also Published As

Publication number Publication date
CZ392588A3 (en) 1996-11-13
DE3889497T2 (de) 1994-08-25
PH25187A (en) 1991-03-27
ES2051846T3 (es) 1994-07-01
JPH078874B2 (ja) 1995-02-01
IL86602A0 (en) 1988-11-30
ZA884115B (en) 1990-02-28
IL86602A (en) 1992-06-21
MY103572A (en) 1993-08-28
KR890000500A (ko) 1989-03-15
US4914101A (en) 1990-04-03
FI89802C (fi) 1993-11-25
PT87678B (pt) 1992-10-30
IE881733L (en) 1988-12-10
PT87678A (pt) 1988-07-01
FI890620A7 (fi) 1989-02-09
IE63214B1 (en) 1995-04-05
KR900006758B1 (ko) 1990-09-20
NO176277C (no) 1995-03-08
EG18525A (en) 1994-04-30
EP0294994A1 (en) 1988-12-14
PL272928A1 (en) 1989-07-10
NO922636D0 (no) 1992-07-03
NO890531D0 (no) 1989-02-08
PL158994B1 (pl) 1992-10-30
NZ224956A (en) 1990-07-26
AU1753588A (en) 1988-12-15
YU46767B (sh) 1994-05-10
CN88103539A (zh) 1988-12-28
NO176277B (no) 1994-11-28
FI890620A0 (fi) 1989-02-09
CA1300625C (en) 1992-05-12
MX11827A (es) 1993-04-01
DD281602A5 (de) 1990-08-15
DK313388D0 (da) 1988-06-09
CZ281857B6 (cs) 1997-03-12
YU111988A (en) 1989-12-31
MX174093B (es) 1994-04-21
DE3889497D1 (de) 1994-06-16
NO922636L (no) 1989-02-08
JPS6413093A (en) 1989-01-17
NO890531L (no) 1989-02-08
ATE105561T1 (de) 1994-05-15
HU203762B (en) 1991-09-30
CN1019576B (zh) 1992-12-23
AU593743B2 (en) 1990-02-15
HUT54376A (en) 1991-02-28
FI89802B (fi) 1993-08-13
WO1988009793A1 (en) 1988-12-15
EP0294994B1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
AU7579094A (en) Methods for the treatment of peri-menopausal syndrome
DE3879264D1 (de) N-substituierte azole.
NO954576L (no) AMPA antagonister og en fremgangsmåte til behandling med dem
EP1331224A4 (en) THIAZOLE AND OXAZOLE DERIVATIVES
DK313388D0 (da) 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-oe1aabenzothienooe3,2-eaa-1,2-thiazin-4-carboxamid-1,1-dioxid-forbindelser, farmaceutiske praeparater indeholdende disse og forbindelser til anvendelse som udgangsmateriale ved deres fremstilling
ES8406072A1 (es) Procedimiento para la preparacion de nuevas sulfonamidas.
WO1995001170A3 (en) Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders
NO305751B1 (no) Substituerte benzensulfonylurinstoffer og -tiourinstoffer, deres anvendelse for fremstilling av medikament eller diagnostikum, sÕvel som legemidler inneholdende forbindelsene
AR228270A1 (es) Procedimiento para preparar derivados de 4-fenil,5-(fenil o 3-piridil)-1h-pirrol-2-metanamina
KR900700450A (ko) 카르바모일-2-피롤리디논 화합물
IT1140847B (it) Tiazoliliden osso propionitrili, mezzi insetticidi contenenti questi composti e processo per la loro preparazione
DK355081A (da) 7-beta-(alfa-syn-methoxyimino-alfa(2-aminothiazol-4-yl) acetamido)-3-( (1,2,3-triadiazol-5-ylthio) methyl)-3-cephem-4-carboxylsyre samt c1-c6-alkylderivater heraf fremgangsmaade til fremstilling heraf samt deres anvendelse som antibakterielle midler
DK38586D0 (da) Fremgangsmaade til desinfektion af kontaktlinser og middel til anvendelse ved fremgangsmaaden samt midlets fremstilling
NO165541C (no) Nye azolylderivater, fungicide preparater inneholdende disse som aktiv fugicid bestanddel og anvendelse av azolylderivater for bekjempelse av fungusinfeksjoner i nytteplanter
NO944577L (no) Hemming av effekten av amyloidogene proteiner
DE3867563D1 (en) 2-amino-5-hydroxy-4-pyrimidone.
JPS5610172A (en) 1-thiocarbamoyl-2-imidazolidinone compound
DE3866729D1 (de) 4-chloroxazol-derivate, verfahren zu ihrer herstellung und ihre verwendung.
ES8604532A1 (es) Procedimiento de preparacion de nuevos derivados as-triazinos condensados
JPS545996A (en) Heterocyclic compounds and process for their preparation
IT8021382V0 (it) Orologio, da muro o da tavolo, in cui il meccanismo dell'orologio colquadrante protetto da vetro e' incassato in una cassa di legno
CS746285A2 (en) Method of as-triazine's new fussed derivatives preparation

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment